Tandem Diabetes Care (TNDM) Convertible Debt (2020 - 2026)

Tandem Diabetes Care (TNDM) has reported Convertible Debt for 7 consecutive years, with $602.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Convertible Debt rose 94.92% year-over-year to $602.6 million; the trailing twelve-month figure through Jun 2026 stood at $602.6 million (up 94.92% YoY), and the FY2025 full-year result was $310.0 million, up 0.57% from the prior year.
• Convertible Debt steadied at $602.6 million in Q2 2026 per TNDM's latest filing, from $601.8 million in the prior quarter.
• Across five years, Convertible Debt topped out at $602.6 million in Q2 2026 and bottomed at $281.9 million in Q1 2022.
• Historically, Convertible Debt has averaged $332.2 million across 5 years, with a median of $307.6 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Convertible Debt decreased 11.16% in 2025, then soared 94.93% in 2026.
• Over 5 years, Convertible Debt stood at $283.2 million in 2022, then gained by 0.64% to $285.0 million in 2023, then advanced by 8.15% to $308.3 million in 2024, then increased by 0.57% to $310.0 million in 2025, then jumped by 94.36% to $602.6 million in 2026.
• According to Business Quant data, Convertible Debt over the past three periods registered $602.6 million, $601.8 million, and $310.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.